187.86

2.87% 5.24

Krystal Biotech Inc (KRYS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché KRYS Giù? Forum Previsione

Precedente Chiudi:

$182.62

Aprire:

$184.99

Volume 24 ore:

291.52K

Relative Volume:

1.13

Capitalizzazione di mercato:

$5.41B

Reddito:

$241.52M

Utile/perdita netta:

$52.37M

Rapporto P/E:

105.54

EPS:

1.78

Flusso di cassa netto:

$58.06M

1 W Prestazione:

+22.59%

1M Prestazione:

+23.96%

6M Prestazione:

-6.83%

1 anno Prestazione:

+73.93%

Intervallo 1D:

$184.12

$189.19

Intervallo di 1 settimana:

$148.00

$190.00

Portata 52W:

$107.50

$219.34

Krystal Biotech Inc Stock (KRYS) Company Profile

Nome

Krystal Biotech Inc

Settore

Healthcare (1169)

Industria

Biotechnology (678)

Telefono

(412) 586-5830

Indirizzo

2100 WHARTON STREET, PITTSBURGH, PA

Dipendente

275

Cinguettio

@KrystalBiotech

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

KRYS's Discussions on Twitter

Confronta KRYS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KRYS Krystal Biotech Inc	187.86	5.41B	241.52M	52.37M	58.06M	1.78
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-06	Downgrade	Citigroup	Buy → Neutral
2023-11-20	Iniziato	Goldman	Buy
2023-10-24	Iniziato	Cantor Fitzgerald	Overweight
2023-10-12	Iniziato	Citigroup	Buy
2023-09-07	Iniziato	Berenberg	Buy
2023-04-18	Iniziato	Stifel	Buy
2023-02-28	Aggiornamento	Goldman	Neutral → Buy
2022-08-25	Downgrade	Goldman	Buy → Neutral
2022-01-18	Iniziato	BofA Securities	Buy
2021-07-20	Aggiornamento	Goldman	Neutral → Buy
2020-09-18	Iniziato	B. Riley FBR	Buy
2020-06-04	Iniziato	Evercore ISI	Outperform
2019-09-24	Iniziato	Goldman	Neutral
2019-08-06	Reiterato	H.C. Wainwright	Buy
2019-06-24	Reiterato	Chardan Capital Markets	Buy
2019-06-24	Reiterato	H.C. Wainwright	Buy
2019-05-30	Iniziato	Guggenheim	Buy
2018-09-11	Iniziato	Cantor Fitzgerald	Overweight

Mostra tutto

Krystal Biotech Inc Borsa (KRYS) Ultime notizie

05:17 AM

William Blair Comments on Krystal Biotech Q1 Earnings - Defense World

05:17 AM

Feb 21, 2025

Krystal Biotech projects EU and Japan launches for VYJUVEK in 2025, targeting $1B global peak sales - MSN

Feb 21, 2025

Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know - MSN

Feb 21, 2025

Krystal Biotech (NASDAQ:KRYS) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

Feb 21, 2025

Chardan Capital Forecasts Strong Price Appreciation for Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat

Feb 21, 2025

Krystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In Focus (KRYS) - Seeking Alpha

Feb 21, 2025

Krystal Biotech (NASDAQ:KRYS) Trading 7.1% Higher on Analyst Upgrade - Defense World

Feb 21, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Holdings Cut by Allspring Global Investments Holdings LLC - Defense World

Feb 21, 2025

Vontobel Holding Ltd. Decreases Stake in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

Feb 21, 2025

Feb 20, 2025

Krystal Biotech Q4 Earnings Beat Estimates, Sales Miss, Stock Up - MSN

Feb 20, 2025

Short Interest in Krystal Biotech, Inc. (NASDAQ:KRYS) Declines By 7.4% - MarketBeat

Feb 20, 2025

Krystal Biotech Earnings Call: Optimism Amid Challenges - TipRanks

Feb 20, 2025

H.C. Wainwright maintains Buy on Krystal stock, $221 target By Investing.com - Investing.com South Africa

Feb 20, 2025

A Glimpse Into The Expert Outlook On Krystal Biotech Through 9 Analysts - Benzinga

Feb 20, 2025

Krystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at HC Wainwright - MarketBeat

Feb 20, 2025

Krystal Biotech (NASDAQ:KRYS) Shares Gap DownWhat's Next? - MarketBeat

Feb 20, 2025

Krystal Biotech (NASDAQ:KRYS) Posts Quarterly Earnings Results, Beats Estimates By $0.23 EPS - MarketBeat

Feb 20, 2025

H.C. Wainwright maintains Buy on Krystal stock, $221 target - Investing.com

Feb 20, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 20, 2025

3 US Growth Companies With High Insider Ownership Expecting Up To 68% Earnings Growth - Simply Wall St

Feb 20, 2025

TimesSquare Capital Management LLC Purchases 44,646 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

Feb 20, 2025

Krystal Biotech’s (KRYS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Feb 20, 2025

Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Feb 20, 2025

Krystal Biotech (KRYS) Expected to Announce Earnings on Wednesday - MarketBeat

Feb 20, 2025